Publication of 2,000 canine genomes provides toolkit for translational research
An international research consortium has generated and analysed 2,000 canine genomes. The resulting advanced genetics toolkit can now be used to answer complex biological questions, spanning dog domestication, genetic differences in breed morphology, behavior and disease susceptibility, as well as the evolution and structure of the genome. The study, published in the journal Genome Biology, describes the toolkit resource package and presents the first set of discoveries.
The publication is the culmination of efforts from the Dog10K consortium — 48 scientists across 25 institutions, contributing samples and resources to the immense analytical effort.
Jennifer Meadows is an Uppsala University research scientist and was a lead co-author of the study. “The goal was to produce a resource the global community could access, and which they could use to speed the translation of their own research, be that in the study of the shared ancestors of dogs and wolves, or the clinical treatment of cancers. All these avenues are exciting, and all can benefit from the Dog10K catalogue,” Meadows said.
The power of the Dog10K analyses lies in the depth of genetic diversity the team was able to capture. Canine samples were drawn from more than 320 of the approximately 400 recognised pedigree dog breeds, as well as niche populations of village dogs, wolves and coyotes.
The team developed:
- A comprehensive catalogue of single nucleotide variants, including those which can disrupt protein coding genes and may influence the extremes of dog appearance and physiology. All pedigree dogs in the study were free from disease when sampled, suggesting that some of the variants that cause a loss of protein function do not cause obvious disease in that population.
- A catalogue of structural variants. This category of variants has a minimum size of 50 base pairs, and so impacts more space in the genome than a single nucleotide variant. Some structural variants were found to impact protein coding genes. This could mean that too much, or too little of the protein is made in that individual, but again did not cause obvious disease in the pedigree population.
- For both single nucleotide and structural variants, the Dog10K team illustrated how these variants are distributed within and between pedigree dog breeds, and how these variants may impact the study of potential drug therapies.
- Publicly available data processing pipelines. Combining the results from different studies can be made more difficult when different settings are used to map sequencing data, and then to call variation. The pipeline used by the Dog10K consortium is open to the community so that new or existing data can be processed and easily combined with this set.
- An imputation panel from the single nucleotide variants. Imputation is a process that allows researchers to infer variation at sites that they did not directly measure. The Dog10K team showed that by using the imputation panel, a dataset that contained 170 thousand single nucleotide sites, commonly used in genotyping array studies, can be expanded to up to 8 million sites. This allows researchers to reuse their valuable samples, and to revisit complex questions that need more data.
“We have just scratched the surface of the data’s potential,” Meadows said. “There is yet more genetic diversity left to be found in dogs, wolves and coyotes, but the Dog10K team looks forward to seeing how this first effort is applied by the canine science community.”
This article was first published by Uppsala University. Read the original.
Enjoy reading ASBMB Today?
Become a member to receive the print edition four times a year and the digital edition monthly.
Learn moreGet the latest from ASBMB Today
Enter your email address, and we’ll send you a weekly email with recent articles, interviews and more.
Latest in Science
Science highlights or most popular articles

Light-activated small molecule could transform eye infection treatment
Contact lenses raise the risk of infectious keratitis, a leading cause of blindness worldwide. A biotech company is commercializing a light-activated therapy using a ROS-generating molecule to rapidly kill microbes in the cornea to preserve vision.

The molecular orchestra of memory
Calcium, calmodulin and calcium/calmodulin-dependent kinase II form a molecular axis that turns fleeting neural activity into lasting memories. New research shows how memories are stabilized, and possibly even protected or repaired.

Differences in pili structure modulate bacterial behavior
Researchers demonstrate how small changes in the structure of hair-like protein appendages can affect the behavior of Acinetobacter bacteria.

Cholesterol regulatory genes predict liver transplant outcomes
Researchers identify a link between cholesterol-regulating genes and liver transplant success, which could improve donor screening and patient outcomes.

Lipid signatures for a rare neurological disorder
Researchers find distinct lipid patterns linked to a rare autoimmune neurological disorder, offering hope for effective targeted therapies for patients.

Disease-linked mutations disrupt protein phase behavior
Researchers find that pathogenic missense mutations are enriched threefold in phrase-separating intrinsically disordered regions of proteins.